Both Switzerland and the United Kingdom are known for being industry leaders in all aspects related to Cell and Gene Therapy. It is for this reason that the Swiss delegation to the University of Cambridge aims to promote the exchange of best practices and key learnings from their respective ecosystems.
Novartis has recently announced its intent to invest up to 90 million Swiss francs to build a production facility for innovative cell and gene therapies in Stein in the canton of Aargau. What does this mean for Switzerland's research landscape? And how can the United Kingdom profit from this? The Swiss Embassy are bringing the UK- and Swiss-based ecosystems together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. Join them for an afternoon filled with exciting presentations and networking opportunities in one of the world's most prestigious Universities.
| TARGET AUDIENCE | UK-based Exporters, Associations, Clusters, Decision / Policy Makers, Government, Innovation Communities (Startups & intermediaries), Academics, Industry Experts |
| ORGANIZER | Swiss Business Hub UK + Ireland, Switzerland Global Enterprise |
| EVENT LANGUAGE |
English |
| PLACE |
Babraham Hall House |
| COST OF PARTICIPATING | Free of charge for UK-based companies |
